KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Invested Capital: 2009-2025

Historic Invested Capital for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Chemed's Invested Capital fell 1287.25% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1287.25%. This contributed to the annual value of $1.1 billion for FY2024, which is 100.35% up from last year.
  • Chemed's Invested Capital amounted to $1.1 billion in Q3 2025, which was down 1287.25% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Chemed's Invested Capital ranged from a high of $1.2 billion in Q3 2024 and a low of $623.3 million during Q4 2021
  • In the last 5 years, Chemed's Invested Capital had a median value of $952.1 million in 2023 and averaged $960.9 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 3083.97% in 2021, then surged by 4031.12% in 2023.
  • Over the past 5 years, Chemed's Invested Capital (Quarter) stood at $623.3 million in 2021, then grew by 28.95% to $803.7 million in 2022, then skyrocketed by 37.84% to $1.1 billion in 2023, then grew by 1.0% to $1.1 billion in 2024, then fell by 3.78% to $1.1 billion in 2025.
  • Its Invested Capital stands at $1.1 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.